Profound MedicalPROF
About: Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
Employees: 142
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
18% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 11
0% more funds holding in top 10
Funds holding in top 10: 2 [Q4 2024] → 2 (+0) [Q1 2025]
3.14% less ownership
Funds ownership: 45.86% [Q4 2024] → 42.73% (-3.14%) [Q1 2025]
6% less funds holding
Funds holding: 52 [Q4 2024] → 49 (-3) [Q1 2025]
29% less capital invested
Capital invested by funds: $103M [Q4 2024] → $73.4M (-$29.7M) [Q1 2025]
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
77% less call options, than puts
Call options by funds: $21K | Put options by funds: $93K
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
Lake Street Benjamin Haynor | 89%upside $11 | Buy Maintained | 23 Apr 2025 |
Financial journalist opinion









